IDH1 and neoplasm: The second point concerns the paradox of proposing an intensive treatment to a population (IDH-mutated/codeleted tumor) with an a priori good prognosis (long-survival expected and lower tendency to progress to more aggressive tumors), while we know the risk of late toxicity due to RT possibly increased by the association with CT.